Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $7.81 | Prev. Close $7.95 | Circuit Range N/A |
Day Range $7.71 - $7.98 | Year Range $5.80 - $11.96 | Volume 1,15,824 |
Average Traded $7.83 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
28-Apr-26 | $8.02 | $7.93 | -1.66% |
27-Apr-26 | $8.21 | $8.06 | -1.90% |
24-Apr-26 | $8.28 | $8.22 | +0.92% |
23-Apr-26 | $8.43 | $8.14 | -3.61% |
22-Apr-26 | $8.58 | $8.45 | -0.59% |
21-Apr-26 | $8.59 | $8.50 | -1.85% |
20-Apr-26 | $8.68 | $8.66 | -1.93% |